Skip to main content

Table 3 Hs-TnI and hs-TnT levels at rest

From: Troponin I levels in permanent atrial fibrillation—impact of rate control and exercise testing

Treatment

Hs-TnI at rest, ng/L

Hs-TnT at rest, ng/L

Decrease in hs-TnI associated with treatment relative to baseline level, ng/L

Decrease in hs-TnT associated with treatment relative to baseline level, ng/L

Decrease in hs-TnI associated with treatment relative to baseline level, %

Decrease in hs-TnT associated with treatment relative to baseline level, %

Baseline

5.2 (3.8, 8.5)

10.0 (7.0, 13.0)

    

Diltiazem

4.5 (3.3, 5.9)

9.0 (7.0, 12.0)

0.14 (0.04, 0.30)

0.14 (0.0, 0.23)

14 %

14 %

Verapamil

4.1 (2.8, 5.6)

8.0 (6.0, 11.0)

0.24 (0.09, 0.41)*

0.18 (0.05, 0.25)

24 %

18 %

Metoprolol

4.1 (2.7, 6.2)

8.0 (6.0, 10.5)

0.18 (0.02, 0.33)

0.14 (0.0, 0.25)

18 %

14 %

Carvedilol

4.5 (3.0, 6.0)

8.0 (6.0, 12.0)

0.18 (0.01, 0.32)

0.13 (0.0, 0.20)

18 %

13 %

  1. Values are expressed as median (25th percentile, 75th percentile). * p < 0.05 compared with hs-TnT
  2. hs-TnI, high-sensitivity troponin I
  3. hs-TnT, high-sensitivity troponin T